End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30,200 KRW | 0.00% | +7.66% | +31.02% |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Sales forecast by analysts have been recently revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Analyst opinion has improved significantly over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+31.02% | 838M | - | ||
+3.89% | 70.44B | A | ||
+10.97% | 8.94B | A- | ||
-16.83% | 4.75B | A- | ||
+43.48% | 4.5B | - | ||
+3.20% | 3.85B | B- | ||
-21.36% | 2.34B | C- | ||
-29.67% | 2.2B | - | ||
+8.38% | 1.96B | - | - | |
+3.90% | 1.65B | D+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- A039200 Stock
- Ratings Oscotec Inc.